ホーム › アトピー性皮膚炎（湿疹） › アラバマ州
アラバマ州におけるアトピー性皮膚炎（湿疹）の臨床試験
アラバマ州内の拠点で、アトピー性皮膚炎（湿疹）に関する9件の研究が参加者を募集しています。
アラバマ州内の都市
公式研究テキスト（英語）
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Cahaba Dermatology & Skin Health Center- Site Number : 8400006, Birmingham
- River Region Dermatology and Laser- Site Number : 8400041, Montgomery
被験者募集中観察研究
12歳以上 · 全性別 · 2026/09/29更新 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Birmingham
- Novartis Investigative Site, Birmingham
被験者募集中第2相
18歳〜100歳 · 全性別 · 2026/09/28更新 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Birmingham
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07298395First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
被験者募集中第1相健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT07527923A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Cahaba Dermatology & Skin Health Center, Birmingham
被験者募集中第3相
2歳〜11歳 · 全性別 · 2026/09/25更新 · NCT06807281A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/08/28更新 · NCT07599813A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Birmingham
被験者募集中第3相
6 Months – 11 Years · 全性別 · 2026/07/07更新 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Cahaba Dermatology & Skin Health Center /ID# 263855, Birmingham
被験者募集中第3相
18歳〜63歳 · 全性別 · 2026/07/06更新 · NCT06389136A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Allervie Clinical Research, Birmingham
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/04更新 · NCT05995964ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。